TriXion Life Sciences
Aerial view of a modern pharmaceutical manufacturing facility at night, symbolising end-to-end value chain services

Services

Connecting the dots across the pharmaceutical value chain

Manufacturers need reach. Customers need certainty. TriXion is built to deliver both sides of that equation without diluting either.

For CROs, CDMOs and CMOs

Marketing representation for manufacturers

We take on the marketing and business development workload for specialised manufacturers — positioning capabilities, qualifying customers and managing the commercial dialogue in Europe and the US.

  • Capability positioning for stringent regulated markets
  • Customer identification, qualification and introduction
  • Commercial dialogue managed end to end

For generic, specialty and licence-holding companies

Qualified sourcing for customers

We present sources that stand up to scrutiny — with clarity on regulatory status, quality posture and supply continuity before a single sample moves.

  • Pre-vetted manufacturers with defensible quality records
  • Regulatory status clarified up front
  • Reduced single-source and continuity exposure

CRO · CDMO · CMO

Strategic partnerships

Long-term partnerships with specialised development and manufacturing organisations, including representation of their capabilities to our customer network.

  • Development partner matchmaking
  • Co-development and technology transfer support
  • Confidentiality-first engagement structure

Raw material to FDF

Value chain integration

One accountable partner across the journey from raw material sourcing to delivery of Finished Dosage Forms, removing intermediaries and information loss.

  • API, granule, pellet and FDF coordination
  • Single point of commercial accountability
  • Documentation flow managed centrally

Expertise spectrum

From molecule to market-ready dose

Each stage of the value chain carries its own technical and regulatory risk. We work across all four, so a project does not lose momentum at the handovers.

Stage 01

APIs & Intermediates

Access to qualified API and intermediate manufacturers with dossier and audit readiness suited to stringent markets.

  • Regulatory status mapping
  • Impurity and stability data review
  • Second-source strategy

Stage 02

DC Granules

Directly compressible granules that shorten formulation timelines and stabilise downstream processing.

  • Flow and compressibility profiling
  • Scale-up support
  • Batch consistency assurance

Stage 03

Pellets & Multiparticulates

Pellet and multiparticulate systems for modified, delayed and dual-release performance.

  • Coating and release design
  • Capsule and sachet formats
  • Technology transfer

Stage 04

Finished Dosage Forms

Finished formulations delivered through a vetted CDMO and CMO network serving the US and Europe.

  • Solid orals and oral solutions
  • Specialised delivery formats
  • Commercial supply continuity

Therapeutic focus

Diverse therapeutic areas, consistent standards

Programmes span multiple therapeutic categories, with the same regulatory discipline applied to each.

  • Oncology
  • Haematology & iron therapy
  • Central nervous system
  • Cardiometabolic
  • Anti-infectives
  • Sleep & neurology

API & Intermediates desk

Sourcing, supply and partnering enquiries for APIs, intermediates, DC granules and pellets.

api.bd@trixionls.com

Finished Dosage Forms desk

Enquiries for finished formulations, CDMO/CMO partnering and regulated-market supply.

fdf.bd@trixionls.com
Open a technical enquiry